Deliver to Peru
For best experience Get the App
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively.
Trustpilot
Sneha T.
Hace 1 mes
Reema J.
Aisha M.
Hace 5 días
Farhan Q.
Hace 2 meses